By resolution of the Board of Directors, Vitruvia Medical AG has resolved to issue a convertible bond (“Private Placement”) of CHF 2.2 million at an interest rate of 6.00% p.a. and a term of 3 years. The issue price is set at 100% and the conversion price is EUR 2.50 and is convertible into registered shares of Vitruvia Medical AG.
The funds will be used to finance existing projects (LT technologies GmbH & Co. KG), acquisitions (rebuilding of the investment portfolio) and general corporate financing.
Anglikon, 26 November 2022
Vitruvia Medical Ltd.
Board of directors
About Vitruvia
Vitruvia Medical AG is a Swiss investment company focusing on the repair, production and trade of medical devices as well as surgical instruments.
Vitruvia thus combines innovative and sustainable solutions for medical-technical progress, customer benefit and economic success.
Contact:
Vitruvia Medical AG
Markus A. Bertschin
Board of Directors
T +41 44 915 33 78
bertschin@vitruvia-med.com